Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis

Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis

US Patent 6592874 · Granted Jul 15, 2003

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Attenuated recombinant alphaviruses incapable of replicating in mosquitoes and u2020
Attenuated recombinant alphaviruses incapable of replicating in mosquitoes and u2017
Methods and compositions for pseudoinfectious alphaviruses2016
Pseudoinfectious flavivirus and uses thereof2016
Methods and compositions for alphavirus replicons2015
Chimeric sindbis-western equine encephalitis virus and uses thereof2014
Compositions and methods for generating an immune response utilizing alphavirus-2014
Attenuation of encephalitogenic alphavirus and uses thereof2013
Attenuated recombinant alphaviruses incapable of replicating in mosquitoes and u2013
Two-component genome flavivirus and uses thereof2013
Chimeric chikungunya virus and uses thereof2013
Pseudoinfectious flavivirus and uses thereof2012